Growth Metrics

Boston Scientific (BSX) Total Current Liabilities (2016 - 2026)

Boston Scientific's Total Current Liabilities history spans 18 years, with the latest figure at $4.6 billion for Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 9.63% to $4.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $4.6 billion, a 9.63% decrease, with the full-year FY2025 number at $5.4 billion, down 15.0% from a year prior.
  • Total Current Liabilities hit $4.6 billion in Q1 2026 for Boston Scientific, down from $5.4 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for BSX hit a ceiling of $6.4 billion in Q4 2024 and a floor of $3.5 billion in Q3 2022.
  • Historically, Total Current Liabilities has averaged $4.8 billion across 5 years, with a median of $4.9 billion in 2024.
  • Biggest five-year swings in Total Current Liabilities: grew 29.72% in 2024 and later decreased 15.0% in 2025.
  • Tracing BSX's Total Current Liabilities over 5 years: stood at $3.8 billion in 2022, then increased by 29.71% to $4.9 billion in 2023, then grew by 29.72% to $6.4 billion in 2024, then fell by 15.0% to $5.4 billion in 2025, then dropped by 15.96% to $4.6 billion in 2026.
  • Business Quant data shows Total Current Liabilities for BSX at $4.6 billion in Q1 2026, $5.4 billion in Q4 2025, and $5.3 billion in Q3 2025.